| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 4.84e-06 | 46 | 108 | 5 | GO:0030020 | |
| GeneOntologyMolecularFunction | chromatin binding | ERCC6 AKAP8 ATRX YBX1 CHAF1A PHF8 ARID1A SBNO2 PARP1 TDRD3 PRDM8 TNRC18 ATAD2B MBD2 | 4.47e-05 | 739 | 108 | 14 | GO:0003682 |
| GeneOntologyBiologicalProcess | extracellular matrix organization | COL2A1 COL5A2 PRSS1 PRSS2 COL9A3 COL13A1 CCDC80 COL24A1 ZNF469 PBXIP1 | 2.48e-05 | 377 | 106 | 10 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | COL2A1 COL5A2 PRSS1 PRSS2 COL9A3 COL13A1 CCDC80 COL24A1 ZNF469 PBXIP1 | 2.54e-05 | 378 | 106 | 10 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | COL2A1 COL5A2 PRSS1 PRSS2 COL9A3 COL13A1 CCDC80 COL24A1 ZNF469 PBXIP1 | 2.59e-05 | 379 | 106 | 10 | GO:0045229 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | SOX3 YBX1 RHOXF2 DNAJB4 ARID1A RFX5 HNRNPL SBNO2 ZNF503 NFE2L3 TBX18 PARP1 RHOXF2B ZNF469 PRDM8 MYOZ1 DNAJB5 MBD2 PBXIP1 | 8.54e-05 | 1399 | 106 | 19 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | SOX3 YBX1 RHOXF2 DNAJB4 ARID1A RFX5 HNRNPL SBNO2 ZNF503 NFE2L3 TBX18 PARP1 RHOXF2B ZNF469 PRDM8 MYOZ1 DNAJB5 MBD2 PBXIP1 | 9.74e-05 | 1413 | 106 | 19 | GO:1902679 |
| GeneOntologyCellularComponent | chromatin | SOX3 FOXJ2 ERCC6 AKAP8 ATRX RHOXF2 CHAF1A SHOX ARID1A RFX5 HNRNPL NFE2L3 TBX18 PARP1 JUNB RHOXF2B ZBED4 DMRTA2 TNKS1BP1 PBX1 EMX1 MBD2 PBXIP1 | 1.58e-06 | 1480 | 108 | 23 | GO:0000785 |
| GeneOntologyCellularComponent | muscle myosin complex | 7.15e-05 | 16 | 108 | 3 | GO:0005859 | |
| GeneOntologyCellularComponent | collagen trimer | 9.34e-05 | 88 | 108 | 5 | GO:0005581 | |
| GeneOntologyCellularComponent | collagen type XI trimer | 2.62e-04 | 5 | 108 | 2 | GO:0005592 | |
| GeneOntologyCellularComponent | myosin filament | 2.84e-04 | 25 | 108 | 3 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin II complex | 4.00e-04 | 28 | 108 | 3 | GO:0016460 | |
| GeneOntologyCellularComponent | myofibril | 5.45e-04 | 273 | 108 | 7 | GO:0030016 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | ERCC6 YBX1 WRAP53 ARID1A RFX5 TSEN2 NFE2L3 TBX18 JUNB TDRD3 PRDM8 AGFG1 DGCR8 PBX1 PPIH MBD2 CSTF2T | 6.81e-04 | 1377 | 108 | 17 | GO:0140513 |
| GeneOntologyCellularComponent | site of DNA damage | 7.30e-04 | 137 | 108 | 5 | GO:0090734 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 7.77e-04 | 290 | 108 | 7 | GO:0043292 | |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 1.69e-03 | 12 | 108 | 2 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 1.69e-03 | 12 | 108 | 2 | GO:0098643 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL2A1 COL5A2 PRSS1 PRSS2 COL9A3 COL13A1 CCDC80 COL24A1 AGRN | 1.72e-03 | 530 | 108 | 9 | GO:0062023 |
| GeneOntologyCellularComponent | sarcomere | 1.87e-03 | 249 | 108 | 6 | GO:0030017 | |
| GeneOntologyCellularComponent | site of double-strand break | 1.87e-03 | 101 | 108 | 4 | GO:0035861 | |
| MousePheno | abnormal skeletal muscle fiber type ratio | 4.61e-06 | 40 | 87 | 5 | MP:0009409 | |
| MousePheno | abnormal synaptic transmission | EPRS1 MYH1 PRSS1 COL13A1 ATRX TRIOBP DNM1L PHF8 DDC PPM1G SLC32A1 PARP1 ADRA1D PRDM8 ZNHIT6 IRGC DLG4 DGCR8 AGRN XKR5 | 6.75e-06 | 1070 | 87 | 20 | MP:0003635 |
| MousePheno | abnormal synaptic physiology | EPRS1 MYH1 PRSS1 COL13A1 ATRX TRIOBP DNM1L PHF8 DDC PPM1G SLC32A1 PARP1 ADRA1D PRDM8 ZNHIT6 IRGC DLG4 DGCR8 AGRN XKR5 | 7.34e-06 | 1076 | 87 | 20 | MP:0021009 |
| MousePheno | abnormal prepulse inhibition | EPRS1 MYH1 PRSS1 TRIOBP DNM1L PPM1G PARP1 ADRA1D PRDM8 ZNHIT6 IRGC DGCR8 XKR5 | 2.86e-05 | 542 | 87 | 13 | MP:0003088 |
| MousePheno | abnormal CNS synaptic transmission | EPRS1 MYH1 PRSS1 ATRX TRIOBP DNM1L PHF8 PPM1G SLC32A1 PARP1 ADRA1D PRDM8 ZNHIT6 IRGC DLG4 DGCR8 AGRN XKR5 | 2.90e-05 | 985 | 87 | 18 | MP:0002206 |
| Domain | DnaJ_C | 1.42e-05 | 9 | 105 | 3 | IPR002939 | |
| Domain | DnaJ_C | 1.42e-05 | 9 | 105 | 3 | PF01556 | |
| Domain | HSP40/DnaJ_pept-bd | 1.42e-05 | 9 | 105 | 3 | IPR008971 | |
| Domain | Fib_collagen_C | 2.76e-05 | 11 | 105 | 3 | IPR000885 | |
| Domain | COLFI | 2.76e-05 | 11 | 105 | 3 | PF01410 | |
| Domain | NC1_FIB | 2.76e-05 | 11 | 105 | 3 | PS51461 | |
| Domain | Fib_collagen_C | 2.76e-05 | 11 | 105 | 3 | PD002078 | |
| Domain | COLFI | 2.76e-05 | 11 | 105 | 3 | SM00038 | |
| Domain | Myosin_N | 7.48e-05 | 15 | 105 | 3 | PF02736 | |
| Domain | Myosin_N | 7.48e-05 | 15 | 105 | 3 | IPR004009 | |
| Domain | AKAP95 | 9.36e-05 | 3 | 105 | 2 | IPR007071 | |
| Domain | ZF_C2H2_AKAP95 | 9.36e-05 | 3 | 105 | 2 | PS51799 | |
| Domain | AKAP95 | 9.36e-05 | 3 | 105 | 2 | PF04988 | |
| Domain | Collagen | 1.17e-04 | 85 | 105 | 5 | IPR008160 | |
| Domain | Collagen | 1.17e-04 | 85 | 105 | 5 | PF01391 | |
| Domain | Myosin_tail_1 | 1.32e-04 | 18 | 105 | 3 | PF01576 | |
| Domain | Myosin_tail | 1.32e-04 | 18 | 105 | 3 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 1.57e-04 | 19 | 105 | 3 | IPR027401 | |
| Domain | - | 1.57e-04 | 19 | 105 | 3 | 4.10.270.10 | |
| Domain | DnaJ_domain_CS | 4.58e-04 | 27 | 105 | 3 | IPR018253 | |
| Domain | GOLGA6L | 4.63e-04 | 6 | 105 | 2 | IPR026737 | |
| Domain | P-loop_NTPase | MYH1 MYH2 MYH4 ERCC6 ATRX DNM1L SBNO2 HNRNPUL2 ATAD2B IRGC DLG4 VCP AGAP2 | 9.34e-04 | 848 | 105 | 13 | IPR027417 |
| Domain | Myosin_head_motor_dom | 1.26e-03 | 38 | 105 | 3 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 1.26e-03 | 38 | 105 | 3 | PS51456 | |
| Domain | Myosin_head | 1.26e-03 | 38 | 105 | 3 | PF00063 | |
| Domain | MYSc | 1.26e-03 | 38 | 105 | 3 | SM00242 | |
| Domain | DnaJ | 2.49e-03 | 48 | 105 | 3 | PF00226 | |
| Domain | DNAJ_1 | 2.64e-03 | 49 | 105 | 3 | PS00636 | |
| Domain | DNAJ_2 | 2.64e-03 | 49 | 105 | 3 | PS50076 | |
| Domain | DnaJ | 2.64e-03 | 49 | 105 | 3 | SM00271 | |
| Domain | - | 2.64e-03 | 49 | 105 | 3 | 1.10.287.110 | |
| Domain | Zip | 2.73e-03 | 14 | 105 | 2 | PF02535 | |
| Domain | ZIP | 2.73e-03 | 14 | 105 | 2 | IPR003689 | |
| Domain | DnaJ_domain | 2.96e-03 | 51 | 105 | 3 | IPR001623 | |
| Domain | - | 3.57e-03 | 16 | 105 | 2 | 1.10.880.10 | |
| Domain | Homeobox_CS | 4.02e-03 | 186 | 105 | 5 | IPR017970 | |
| Domain | GOLGA2L5 | 4.52e-03 | 18 | 105 | 2 | PF15070 | |
| Domain | Golgin_A | 4.52e-03 | 18 | 105 | 2 | IPR024858 | |
| Domain | Cyclophilin-type_PPIase_CS | 5.03e-03 | 19 | 105 | 2 | IPR020892 | |
| Domain | UBA-like | 5.61e-03 | 64 | 105 | 3 | IPR009060 | |
| Domain | Cyclophilin-type_PPIase | 6.13e-03 | 21 | 105 | 2 | IPR024936 | |
| Domain | Cyclophilin-like_dom | 6.72e-03 | 22 | 105 | 2 | IPR029000 | |
| Domain | CSA_PPIASE_2 | 6.72e-03 | 22 | 105 | 2 | PS50072 | |
| Domain | Pro_isomerase | 6.72e-03 | 22 | 105 | 2 | PF00160 | |
| Domain | - | 6.72e-03 | 22 | 105 | 2 | 2.40.100.10 | |
| Domain | Cyclophilin-type_PPIase_dom | 6.72e-03 | 22 | 105 | 2 | IPR002130 | |
| Domain | CSA_PPIASE_1 | 6.72e-03 | 22 | 105 | 2 | PS00170 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 2.81e-06 | 44 | 72 | 5 | M27812 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.82e-05 | 64 | 72 | 5 | M26953 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 2.28e-05 | 67 | 72 | 5 | M26999 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 5.49e-05 | 41 | 72 | 4 | MM15538 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 6.05e-05 | 42 | 72 | 4 | M7169 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 7.21e-05 | 85 | 72 | 5 | M16441 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 7.86e-05 | 140 | 72 | 6 | M587 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 8.68e-05 | 46 | 72 | 4 | M198 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 9.45e-05 | 47 | 72 | 4 | MM14925 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 9.47e-05 | 90 | 72 | 5 | M631 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.37e-04 | 20 | 72 | 3 | MM15061 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.41e-04 | 300 | 72 | 8 | M610 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.52e-04 | 53 | 72 | 4 | MM14566 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 2.62e-04 | 61 | 72 | 4 | M27103 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 2.62e-04 | 61 | 72 | 4 | MM14637 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 2.88e-04 | 114 | 72 | 5 | MM14571 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 2.97e-04 | 63 | 72 | 4 | M11187 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 3.39e-04 | 258 | 72 | 7 | MM14572 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 4.70e-04 | 30 | 72 | 3 | M27772 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 5.50e-04 | 74 | 72 | 4 | M160 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 6.08e-04 | 76 | 72 | 4 | MM14867 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 6.08e-04 | 76 | 72 | 4 | M27219 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 6.08e-04 | 76 | 72 | 4 | MM14573 | |
| Pathway | REACTOME_ZINC_INFLUX_INTO_CELLS_BY_THE_SLC39_GENE_FAMILY | 7.06e-04 | 8 | 72 | 2 | MM15106 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 9.48e-04 | 38 | 72 | 3 | MM14969 | |
| Pathway | REACTOME_ZINC_INFLUX_INTO_CELLS_BY_THE_SLC39_GENE_FAMILY | 1.13e-03 | 10 | 72 | 2 | M27361 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.18e-03 | 41 | 72 | 3 | M27778 | |
| Pathway | REACTOME_ZINC_TRANSPORTERS | 1.37e-03 | 11 | 72 | 2 | MM15101 | |
| Pathway | REACTOME_ALPHA_DEFENSINS | 1.37e-03 | 11 | 72 | 2 | MM14569 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | KRT9 ZNF326 AKAP8 YBX1 TRIOBP SRP68 GPATCH8 ARID1A HNRNPL PARP1 ZBED4 HNRNPUL2 IRAK4 TNKS1BP1 PPIH DNAJA1 AGRN PBXIP1 CSTF2T VCP | 2.23e-10 | 1082 | 111 | 20 | 38697112 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | EPRS1 ATRX MAP4 CHAF1A SRP68 DNM1L HUWE1 GPATCH8 HNRNPL PARP1 AHNAK DNAJA1 | 7.96e-10 | 332 | 111 | 12 | 32786267 |
| Pubmed | ATRX MAP4 CHAF1A DNAJB4 DNM1L PSMD3 GPATCH8 PHF8 PPM1G PARP1 JUNB HNRNPUL2 AHNAK PPIH MBD2 DNAJA1 CSTF2T VCP | 3.71e-09 | 1014 | 111 | 18 | 32416067 | |
| Pubmed | EPRS1 ZNF326 AKAP8 MAP4 YBX1 SRP68 PSMD3 HNRNPL PARP1 HNRNPUL2 AHNAK DNAJA1 VCP | 6.94e-09 | 494 | 111 | 13 | 26831064 | |
| Pubmed | EPRS1 MAP4 YBX1 PSMD3 HUWE1 PPM1G PARP1 JUNB AHNAK TNKS1BP1 DNAJA1 PBXIP1 | 1.05e-08 | 418 | 111 | 12 | 35338135 | |
| Pubmed | PRSS1 ZNF326 AKAP8 ATRX YBX1 ZBTB9 SRP68 PSMD3 GPATCH8 PHF8 ARID1A RFX5 HNRNPL PPM1G ZNF503 JUNB HNRNPUL2 PBX1 MBD2 DNAJA1 | 2.50e-08 | 1429 | 111 | 20 | 35140242 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | EPRS1 KRT9 AKAP8 MAP4 YBX1 DNAJB4 SRP68 DNM1L PSMD3 HUWE1 HNRNPL PPM1G PARP1 AHNAK AGFG1 PPIH DNAJA1 VCP | 2.52e-08 | 1149 | 111 | 18 | 35446349 |
| Pubmed | Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation. | 3.16e-08 | 3 | 111 | 3 | 26059207 | |
| Pubmed | Trypsin-mediated enzymatic degradation of type II collagen in the human vitreous. | 3.16e-08 | 3 | 111 | 3 | 23882137 | |
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 11073713 | ||
| Pubmed | The origin of trypsin: evidence for multiple gene duplications in trypsins. | 3.16e-08 | 3 | 111 | 3 | 9732462 | |
| Pubmed | EPRS1 MAP4 YBX1 SRP68 PSMD3 HUWE1 HNRNPL PPM1G HNRNPUL2 TRIM56 DNAJA1 VCP | 3.71e-08 | 469 | 111 | 12 | 37314180 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | EPRS1 PRSS1 ZNF326 YBX1 SRP68 PSMD3 HUWE1 HNRNPL PARP1 AHNAK PIWIL3 VCP | 4.46e-08 | 477 | 111 | 12 | 31300519 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | EPRS1 ZNF326 ATRX MAP4 YBX1 CHAF1A ZBTB9 ARID1A RFX5 HNRNPL PARP1 AHNAK ATAD2B AGFG1 DGCR8 ALK | 6.49e-08 | 954 | 111 | 16 | 36373674 |
| Pubmed | EPRS1 COL5A2 MAP4 SRP68 PSMD3 HUWE1 PARP1 AHNAK TNKS1BP1 DNAJA1 SLC39A7 | 6.70e-08 | 399 | 111 | 11 | 37536630 | |
| Pubmed | ERCC6 AKAP8 DSC2 CHAF1A ZBTB9 PHF8 ARID1A ZNF469 ZNHIT6 TRIM56 DLG4 PPIH MBD2 DNAJA1 SLC39A7 VCP ZNF646 | 9.60e-08 | 1116 | 111 | 17 | 31753913 | |
| Pubmed | DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization. | 9.94e-08 | 175 | 111 | 8 | 25756610 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | ZNF326 AKAP8 YBX1 CHAF1A PSMD3 HUWE1 GPATCH8 HNRNPL PPM1G PARP1 JUNB AHNAK DGCR8 MBD2 DNAJA1 VCP | 1.06e-07 | 989 | 111 | 16 | 36424410 |
| Pubmed | Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle. | 1.26e-07 | 4 | 111 | 3 | 11029314 | |
| Pubmed | Modulation of skeletal muscle fiber type by mitogen-activated protein kinase signaling. | 1.26e-07 | 4 | 111 | 3 | 18417546 | |
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 10388558 | ||
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 11023856 | ||
| Pubmed | EPRS1 ATRX TRIOBP HUWE1 ARMCX4 WRAP53 ARID1A RFX5 SH2B1 NFE2L3 PARP1 DLG4 DGCR8 PBX1 DNAJA1 PBXIP1 VCP AGAP2 | 1.35e-07 | 1285 | 111 | 18 | 35914814 | |
| Pubmed | MYH2 ZNF326 AKAP8 YBX1 TRIOBP PSMD3 HUWE1 HNRNPL PPM1G PARP1 JUNB HNRNPUL2 AHNAK TNKS1BP1 DNAJA1 PBXIP1 SLC39A7 VCP HERC5 | 1.46e-07 | 1440 | 111 | 19 | 30833792 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | ZNF326 ERCC6 AKAP8 MAP4 YBX1 SRP68 PSMD3 TACC2 PHF8 TDRD3 HNRNPUL2 DGCR8 DNAJA1 HERC5 | 1.47e-07 | 759 | 111 | 14 | 35915203 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | EPRS1 ZNF326 ERCC6 MAP4 YBX1 SRP68 PSMD3 HUWE1 PHF8 ARID1A HNRNPL PARP1 HNRNPUL2 AHNAK PPIH DNAJA1 AGRN VCP | 2.87e-07 | 1353 | 111 | 18 | 29467282 |
| Pubmed | EPRS1 PRSS2 KRT9 MAP4 YBX1 PSMD3 ARID1A HNRNPL PARP1 HNRNPUL2 AHNAK DNAJA1 AGRN VCP | 2.91e-07 | 803 | 111 | 14 | 36517590 | |
| Pubmed | Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro. | 3.15e-07 | 5 | 111 | 3 | 3829126 | |
| Pubmed | Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development. | 3.15e-07 | 5 | 111 | 3 | 12919077 | |
| Pubmed | Detection of Gene and Protein Expression in Mouse Embryos and Tissue Sections. | 3.15e-07 | 5 | 111 | 3 | 30737693 | |
| Pubmed | 3.15e-07 | 5 | 111 | 3 | 6196357 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | ZNF326 AKAP8 ATRX SRP68 DNM1L PSMD3 HUWE1 ARID1A PARP1 AHNAK TNKS1BP1 DNAJA1 | 3.78e-07 | 582 | 111 | 12 | 20467437 |
| Pubmed | EPRS1 MAP4 YBX1 ZBTB9 SRP68 ARID1A RFX5 HNRNPL PPM1G ZNF503 PARP1 JUNB TNRC18 PPIH MBD2 CSTF2T | 4.56e-07 | 1103 | 111 | 16 | 34189442 | |
| Pubmed | EPRS1 AKAP8 MAP4 YBX1 SRP68 PSMD3 HUWE1 PHF8 HNRNPL PPM1G ZNF503 PARP1 ZNHIT6 PPIH DNAJA1 | 4.92e-07 | 971 | 111 | 15 | 33306668 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | EPRS1 KRT9 ZNF326 ERCC6 AKAP8 MAP4 YBX1 SRP68 PSMD3 HNRNPL PPM1G PARP1 HNRNPUL2 AHNAK TRIM56 TNKS1BP1 DNAJA1 | 5.09e-07 | 1257 | 111 | 17 | 36526897 |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | EPRS1 PRSS1 KRT9 ZNF326 AKAP8 YBX1 SRP68 ARID1A HNRNPL PARP1 HNRNPUL2 MBD2 | 5.68e-07 | 605 | 111 | 12 | 28977666 |
| Pubmed | 6.28e-07 | 6 | 111 | 3 | 1728586 | ||
| Pubmed | 6.28e-07 | 6 | 111 | 3 | 20417199 | ||
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 6.28e-07 | 6 | 111 | 3 | 10077619 | |
| Pubmed | A role for Insulin-like growth factor 2 in specification of the fast skeletal muscle fibre. | 6.28e-07 | 6 | 111 | 3 | 17559643 | |
| Pubmed | Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. | 6.28e-07 | 6 | 111 | 3 | 10588881 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | EPRS1 MYH1 MYH4 SRP68 HUWE1 PHF8 HNRNPL TDRD3 ADRA1D ZBED4 AHNAK ATAD2B DNAJA1 | 6.89e-07 | 736 | 111 | 13 | 29676528 |
| Pubmed | 7.33e-07 | 156 | 111 | 7 | 32850835 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | EPRS1 ZNF326 AKAP8 ATRX CHAF1A GPATCH8 PHF8 ARID1A RFX5 HNRNPL PARP1 JUNB ZBED4 AHNAK PPIH MBD2 DNAJA1 | 7.59e-07 | 1294 | 111 | 17 | 30804502 |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | MYH2 PRSS1 KRT9 YBX1 C4orf54 HNRNPL PRSS3P2 PARP1 AHNAK TNKS1BP1 DNAJA1 VCP | 8.13e-07 | 626 | 111 | 12 | 33644029 |
| Pubmed | EPRS1 KRT9 MAP4 YBX1 SRP68 PSMD3 PHF8 HNRNPL PPM1G ZNF503 PARP1 HNRNPUL2 PPIH DNAJA1 VCP CCDC107 | 8.16e-07 | 1153 | 111 | 16 | 29845934 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | ZNF326 AKAP8 YBX1 TRIOBP DNAJB4 TACC2 WRAP53 ARID1A TSEN2 ZNHIT6 HNRNPUL2 AHNAK TNKS1BP1 PPIH DNAJA1 VCP | 8.35e-07 | 1155 | 111 | 16 | 20360068 |
| Pubmed | EIF3H Orchestrates Hippo Pathway-Mediated Oncogenesis via Catalytic Control of YAP Stability. | 9.26e-07 | 55 | 111 | 5 | 32269044 | |
| Pubmed | 9.45e-07 | 162 | 111 | 7 | 25796446 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | EPRS1 PRSS1 KRT9 ZNF326 MAP4 YBX1 CHAF1A SRP68 DNM1L PSMD3 HUWE1 WRAP53 HNRNPL PARP1 HNRNPUL2 AHNAK AGRN | 9.76e-07 | 1318 | 111 | 17 | 30463901 |
| Pubmed | EPRS1 ZNF326 DNAJB4 SRP68 DNM1L PSMD3 HUWE1 HNRNPL PARP1 DNAJB5 DNAJA1 VCP | 9.91e-07 | 638 | 111 | 12 | 33239621 | |
| Pubmed | 1.10e-06 | 7 | 111 | 3 | 35210422 | ||
| Pubmed | ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism. | 1.10e-06 | 7 | 111 | 3 | 29758057 | |
| Pubmed | 1.10e-06 | 7 | 111 | 3 | 16819597 | ||
| Pubmed | COL5A2 AKAP8 CHAF1A GPATCH8 ARID1A RFX5 PPM1G PARP1 DGCR8 CSTF2T | 1.15e-06 | 425 | 111 | 10 | 24999758 | |
| Pubmed | ZNF326 ERCC6 AKAP8 ATRX MAP4 CHAF1A TRIOBP SRP68 GPATCH8 WRAP53 JUNB TDRD3 TRIM56 DGCR8 MBD2 AGRN PBXIP1 CSTF2T | 1.23e-06 | 1497 | 111 | 18 | 31527615 | |
| Pubmed | 1.24e-06 | 244 | 111 | 8 | 28902428 | ||
| Pubmed | 1.27e-06 | 332 | 111 | 9 | 37433992 | ||
| Pubmed | EPRS1 MYH1 ZNF326 ATRX CHAF1A PSMD3 PPM1G PARP1 AHNAK AGFG1 TNKS1BP1 | 1.29e-06 | 538 | 111 | 11 | 28524877 | |
| Pubmed | EPRS1 AKAP8 MAP4 YBX1 SRP68 HNRNPL PPM1G TNRC18 HNRNPUL2 TRIM56 MBD2 DNAJA1 | 1.30e-06 | 655 | 111 | 12 | 35819319 | |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | SOX3 FOXJ2 YBX1 RHOXF2 SHOX RFX5 TBX18 JUNB DMRTA2 PBX1 EMX1 | 1.43e-06 | 544 | 111 | 11 | 28473536 |
| Pubmed | 1.53e-06 | 251 | 111 | 8 | 28077445 | ||
| Pubmed | EPRS1 ZNF326 AKAP8 MAP4 YBX1 PSMD3 HUWE1 HNRNPL PARP1 HNRNPUL2 VCP | 1.62e-06 | 551 | 111 | 11 | 34728620 | |
| Pubmed | COL2A1 EPRS1 COL5A2 ZNF326 AKAP8 MAP4 YBX1 SRP68 WRAP53 PARP1 AHNAK TRIM56 PPIH MBD2 ALK SLC39A7 VCP | 1.67e-06 | 1371 | 111 | 17 | 36244648 | |
| Pubmed | 1.71e-06 | 177 | 111 | 7 | 26206133 | ||
| Pubmed | 1.75e-06 | 8 | 111 | 3 | 33667029 | ||
| Pubmed | Hypermutation of immunoglobulin genes in memory B cells of DNA repair-deficient mice. | 1.75e-06 | 8 | 111 | 3 | 9607915 | |
| Pubmed | A Tcf4-positive mesodermal population provides a prepattern for vertebrate limb muscle patterning. | 1.75e-06 | 8 | 111 | 3 | 14667415 | |
| Pubmed | 1.75e-06 | 8 | 111 | 3 | 26993635 | ||
| Pubmed | 2.46e-06 | 187 | 111 | 7 | 29777862 | ||
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 2.49e-06 | 268 | 111 | 8 | 33024031 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | EPRS1 KRT9 MAP4 YBX1 DNAJB4 SRP68 PSMD3 TACC2 HUWE1 HNRNPL PPM1G PARP1 AHNAK TNKS1BP1 PPIH DNAJA1 VCP | 2.55e-06 | 1415 | 111 | 17 | 28515276 |
| Pubmed | 2.62e-06 | 9 | 111 | 3 | 31960486 | ||
| Pubmed | EPRS1 DSC2 MAP4 SRP68 DNM1L PSMD3 PPM1G PARP1 AHNAK TNKS1BP1 DNAJA1 VCP | 2.90e-06 | 708 | 111 | 12 | 39231216 | |
| Pubmed | 2.94e-06 | 274 | 111 | 8 | 34244482 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | PRSS2 KRT9 ATRX TACC2 HUWE1 ARID1A PPM1G TDRD3 AGFG1 TNKS1BP1 DNAJA1 | 3.03e-06 | 588 | 111 | 11 | 38580884 |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | EPRS1 ZNF326 AKAP8 YBX1 PSMD3 GPATCH8 HNRNPL PARP1 HNRNPUL2 PPIH DNAJA1 VCP | 3.16e-06 | 714 | 111 | 12 | 28302793 |
| Pubmed | EPRS1 MYH1 MYH2 MYH4 ATRX YBX1 CHAF1A PSMD3 ARID1A NFE2L3 PARP1 PRDM8 TNRC18 ZBED4 AHNAK DNAJA1 AGAP2 | 3.28e-06 | 1442 | 111 | 17 | 35575683 | |
| Pubmed | EPRS1 MAP4 YBX1 TRIOBP PSMD3 TACC2 HUWE1 PPM1G TNRC18 HNRNPUL2 DLG4 DNAJA1 SLC39A7 VCP AGAP2 | 3.52e-06 | 1139 | 111 | 15 | 36417873 | |
| Pubmed | FGF11 induced by hypoxia interacts with HIF-1α and enhances its stability. | 3.65e-06 | 128 | 111 | 6 | 28027390 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | EPRS1 MAP4 YBX1 DNAJB4 SRP68 DNM1L PSMD3 HUWE1 TSEN2 PPM1G ZNF503 HNRNPUL2 AHNAK AGFG1 TNKS1BP1 DNAJA1 VCP | 3.70e-06 | 1455 | 111 | 17 | 22863883 |
| Pubmed | MBD5 and MBD6 stabilize the BAP1 complex and promote BAP1-dependent cancer. | 4.13e-06 | 287 | 111 | 8 | 36180891 | |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 4.23e-06 | 203 | 111 | 7 | 22083510 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 4.96e-06 | 135 | 111 | 6 | 28675934 | |
| Pubmed | 5.12e-06 | 11 | 111 | 3 | 18310078 | ||
| Pubmed | 5.12e-06 | 11 | 111 | 3 | 8136524 | ||
| Pubmed | Calcineurin is necessary for the maintenance but not embryonic development of slow muscle fibers. | 5.12e-06 | 11 | 111 | 3 | 16024798 | |
| Pubmed | Extracellular matrix protein composition dynamically changes during murine forelimb development. | 5.12e-06 | 11 | 111 | 3 | 38303699 | |
| Pubmed | The histone code reader Spin1 controls skeletal muscle development. | 5.12e-06 | 11 | 111 | 3 | 29168801 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 5.13e-06 | 394 | 111 | 9 | 27248496 | |
| Pubmed | GPATCH8 HNRNPL PPM1G ZNF503 PARP1 AHNAK TNKS1BP1 DNAJA1 CSTF2T | 5.67e-06 | 399 | 111 | 9 | 35987950 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | SOX3 FOXJ2 YBX1 RHOXF2 SHOX RFX5 NFE2L3 TBX18 JUNB ZBED4 DMRTA2 PBX1 EMX1 | 6.84e-06 | 908 | 111 | 13 | 19274049 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | EPRS1 AKAP8 ATRX MAP4 CHAF1A HUWE1 GPATCH8 PHF8 WRAP53 JUNB TNKS1BP1 CSTF2T | 7.15e-06 | 774 | 111 | 12 | 15302935 |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 7.16e-06 | 220 | 111 | 7 | 35785414 | |
| Pubmed | KRT9 ZNF326 AKAP8 DSC2 YBX1 SRP68 DNM1L HUWE1 PPM1G CD99 AHNAK DGCR8 | 7.44e-06 | 777 | 111 | 12 | 35844135 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | EPRS1 MYH1 MYH2 MYH4 CCDC80 PSMD3 HUWE1 AHNAK TNKS1BP1 DNAJA1 VCP | 7.47e-06 | 647 | 111 | 11 | 26618866 |
| Pubmed | MAP4 SRP68 HUWE1 ARID1A PPM1G AHNAK ATAD2B TNKS1BP1 DNAJA1 VCP HERC5 | 8.15e-06 | 653 | 111 | 11 | 22586326 | |
| Pubmed | The von Hippel-Lindau Cullin-RING E3 ubiquitin ligase regulates APOBEC3 cytidine deaminases. | 8.22e-06 | 40 | 111 | 4 | 34004371 | |
| Pubmed | Upregulation of RIN3 induces endosomal dysfunction in Alzheimer's disease. | 8.24e-06 | 418 | 111 | 9 | 32552912 | |
| Pubmed | 8.72e-06 | 421 | 111 | 9 | 34650049 | ||
| Interaction | TLE3 interactions | FOXJ2 MYH1 MYH2 MYH4 AKAP8 GPATCH8 ARID1A HNRNPL PPM1G ZNF503 TNRC18 TNKS1BP1 VCP | 1.40e-07 | 376 | 110 | 13 | int:TLE3 |
| Interaction | ACTN4 interactions | EPRS1 MYH2 YBX1 DNM1L HUWE1 ARID1A HNRNPL MYOZ1 AHNAK AGRN ALK VCP AGAP2 | 2.84e-07 | 400 | 110 | 13 | int:ACTN4 |
| Interaction | MECP2 interactions | KRT9 ZNF326 AKAP8 ATRX YBX1 TRIOBP SRP68 GPATCH8 ARID1A HNRNPL PARP1 ZBED4 HNRNPUL2 IRAK4 TNKS1BP1 DGCR8 PPIH MBD2 DNAJA1 AGRN PBXIP1 CSTF2T VCP | 3.70e-07 | 1287 | 110 | 23 | int:MECP2 |
| Interaction | SUMO2 interactions | EPRS1 ERCC6 ATRX MAP4 CHAF1A SRP68 DNM1L HUWE1 GPATCH8 PHF8 HNRNPL PARP1 AHNAK DNAJA1 VCP | 7.69e-07 | 591 | 110 | 15 | int:SUMO2 |
| Interaction | PRKACB interactions | 1.14e-06 | 193 | 110 | 9 | int:PRKACB | |
| Interaction | HECTD1 interactions | EPRS1 ZNF326 ERCC6 AKAP8 MAP4 YBX1 SRP68 PSMD3 TACC2 HUWE1 PHF8 HNRNPL PARP1 TDRD3 HNRNPUL2 DGCR8 DNAJA1 VCP HERC5 | 1.46e-06 | 984 | 110 | 19 | int:HECTD1 |
| Interaction | ESRRB interactions | ZNF326 AKAP8 CHAF1A ZBTB9 ARID1A JUNB HNRNPUL2 AHNAK DNAJA1 SLC39A7 | 1.74e-06 | 262 | 110 | 10 | int:ESRRB |
| Interaction | HSPH1 interactions | CHAF1A DNAJB4 DNM1L PSMD3 HUWE1 PPM1G DNAJB5 EMX1 MBD2 DNAJA1 ALK VCP | 6.18e-06 | 448 | 110 | 12 | int:HSPH1 |
| Interaction | SMC5 interactions | EPRS1 MYH1 MYH4 ZNF326 ATRX MAP4 YBX1 CHAF1A ZBTB9 ARID1A RFX5 HNRNPL PARP1 AHNAK ATAD2B AGFG1 DGCR8 ALK | 7.54e-06 | 1000 | 110 | 18 | int:SMC5 |
| Interaction | EWSR1 interactions | COL5A2 ZNF326 AKAP8 YBX1 RHOXF2 CHAF1A GPATCH8 ARID1A RFX5 HNRNPL PPM1G PARP1 TDRD3 DGCR8 AGRN CSTF2T VCP | 8.13e-06 | 906 | 110 | 17 | int:EWSR1 |
| Interaction | FBXW11 interactions | EPRS1 ZNF326 AKAP8 YBX1 TRIOBP DNAJB4 HUWE1 HNRNPL HNRNPUL2 DNAJB5 CSTF2T VCP | 1.07e-05 | 473 | 110 | 12 | int:FBXW11 |
| Interaction | FBXO42 interactions | 1.25e-05 | 259 | 110 | 9 | int:FBXO42 | |
| Interaction | BRCA1 interactions | EPRS1 ZNF326 ERCC6 AKAP8 MAP4 YBX1 CHAF1A SRP68 PSMD3 HUWE1 ARID1A SH2B1 HNRNPL PARP1 JUNB MYOZ1 HNRNPUL2 AHNAK DNAJA1 VCP | 1.25e-05 | 1249 | 110 | 20 | int:BRCA1 |
| Interaction | CHD4 interactions | FOXJ2 EPRS1 PRSS1 KRT9 ZNF326 ERCC6 AKAP8 CHAF1A SRP68 GPATCH8 ARID1A HNRNPL PARP1 HNRNPUL2 AHNAK MBD2 DNAJA1 | 1.28e-05 | 938 | 110 | 17 | int:CHD4 |
| Interaction | ISG15 interactions | EPRS1 KRT9 MAP4 YBX1 DNAJB4 PSMD3 HNRNPL PARP1 AHNAK DNAJB5 VCP HERC5 | 1.64e-05 | 494 | 110 | 12 | int:ISG15 |
| Interaction | NUDCD3 interactions | 1.77e-05 | 149 | 110 | 7 | int:NUDCD3 | |
| Interaction | SBNO2 interactions | 1.85e-05 | 10 | 110 | 3 | int:SBNO2 | |
| Interaction | PINK1 interactions | EPRS1 PRSS1 ZNF326 DSC2 YBX1 SRP68 DNM1L PSMD3 HUWE1 HNRNPL PARP1 AHNAK PIWIL3 VCP | 1.97e-05 | 679 | 110 | 14 | int:PINK1 |
| Interaction | PRPF8 interactions | EPRS1 KRT9 ERCC6 MAP4 YBX1 CHAF1A DNAJB4 HUWE1 PPM1G PARP1 AHNAK PPIH DNAJA1 AGRN VCP | 2.07e-05 | 776 | 110 | 15 | int:PRPF8 |
| Interaction | H2AX interactions | ATRX YBX1 CHAF1A HUWE1 GPATCH8 WRAP53 ARID1A PPM1G PARP1 TNRC18 HNRNPUL2 MBD2 VCP | 2.11e-05 | 593 | 110 | 13 | int:H2AX |
| Interaction | PYHIN1 interactions | ZNF326 AKAP8 ATRX HUWE1 HNRNPL PPM1G PARP1 AGRN HERC5 ZNF646 | 2.68e-05 | 358 | 110 | 10 | int:PYHIN1 |
| Interaction | HDAC1 interactions | MYH1 MYH2 MYH4 ERCC6 ATRX CHAF1A ZBTB9 ARID1A PARP1 TNRC18 AHNAK TNKS1BP1 PBX1 MBD2 DNAJA1 SLC39A7 CSTF2T HERC5 | 2.99e-05 | 1108 | 110 | 18 | int:HDAC1 |
| Interaction | MOB3C interactions | EPRS1 COL5A2 MAP4 SRP68 PSMD3 HUWE1 PARP1 AHNAK TNKS1BP1 DNAJA1 | 3.09e-05 | 364 | 110 | 10 | int:MOB3C |
| Interaction | AHSA1 interactions | 3.39e-05 | 294 | 110 | 9 | int:AHSA1 | |
| Interaction | ACTN2 interactions | 4.28e-05 | 171 | 110 | 7 | int:ACTN2 | |
| Interaction | TMEM260 interactions | 4.35e-05 | 13 | 110 | 3 | int:TMEM260 | |
| Interaction | MEX3A interactions | COL5A2 HUWE1 ARID1A PARP1 TDRD3 TNRC18 ZBED4 AHNAK TNKS1BP1 VCP | 4.85e-05 | 384 | 110 | 10 | int:MEX3A |
| Interaction | GATAD2B interactions | 6.00e-05 | 245 | 110 | 8 | int:GATAD2B | |
| Interaction | FZR1 interactions | EPRS1 AKAP8 MAP4 YBX1 SRP68 DNM1L PSMD3 HUWE1 PHF8 HNRNPL PPM1G ZNF503 PARP1 ZNHIT6 HNRNPUL2 DLG4 PPIH DNAJA1 | 6.21e-05 | 1172 | 110 | 18 | int:FZR1 |
| Interaction | NANOG interactions | KRT9 ZNF326 AKAP8 RHOXF2 HUWE1 GPATCH8 ARID1A PARP1 HNRNPUL2 MBD2 DNAJA1 | 6.50e-05 | 481 | 110 | 11 | int:NANOG |
| Interaction | RBBP4 interactions | ERCC6 CHAF1A DNM1L PSMD3 HUWE1 ARID1A HNRNPL TNRC18 HNRNPUL2 MBD2 DNAJA1 VCP | 6.94e-05 | 573 | 110 | 12 | int:RBBP4 |
| Interaction | HDAC2 interactions | FOXJ2 KRT9 ERCC6 MAP4 CHAF1A HUWE1 ARID1A RFX5 PARP1 AHNAK AGFG1 TNKS1BP1 MBD2 DNAJA1 VCP | 7.16e-05 | 865 | 110 | 15 | int:HDAC2 |
| Interaction | RUVBL1 interactions | AKAP8 CHAF1A DNM1L PSMD3 HUWE1 ARID1A JUNB ZNHIT6 AHNAK DLG4 DNAJA1 VCP | 7.18e-05 | 575 | 110 | 12 | int:RUVBL1 |
| Interaction | CYLD interactions | EPRS1 KRT9 MAP4 YBX1 PSMD3 HUWE1 HNRNPL PARP1 AHNAK TRIM56 DLG4 TNKS1BP1 DNAJA1 ALK VCP | 7.45e-05 | 868 | 110 | 15 | int:CYLD |
| Interaction | SOX2 interactions | SOX3 EPRS1 COL13A1 AKAP8 DSC2 YBX1 TRIOBP SRP68 DNM1L PSMD3 ARID1A HNRNPL PARP1 TNRC18 HNRNPUL2 TRIM56 DGCR8 PPIH MBD2 DNAJA1 | 7.87e-05 | 1422 | 110 | 20 | int:SOX2 |
| Interaction | TES interactions | 8.66e-05 | 332 | 110 | 9 | int:TES | |
| Interaction | NLRP8 interactions | 8.83e-05 | 3 | 110 | 2 | int:NLRP8 | |
| Interaction | EEF1D interactions | 8.86e-05 | 333 | 110 | 9 | int:EEF1D | |
| Interaction | ST13 interactions | 9.79e-05 | 195 | 110 | 7 | int:ST13 | |
| Interaction | HUWE1 interactions | EPRS1 PRSS1 ZNF326 CHAF1A SRP68 PSMD3 HUWE1 HNRNPL PPM1G PARP1 HNRNPUL2 DLG4 PBX1 PPIH DNAJA1 VCP HERC5 | 1.05e-04 | 1110 | 110 | 17 | int:HUWE1 |
| Interaction | BAG5 interactions | 1.06e-04 | 341 | 110 | 9 | int:BAG5 | |
| Interaction | TRIM56 interactions | 1.06e-04 | 137 | 110 | 6 | int:TRIM56 | |
| Interaction | RO60 interactions | 1.15e-04 | 200 | 110 | 7 | int:RO60 | |
| Interaction | CEBPA interactions | EPRS1 MAP4 YBX1 ZBTB9 SRP68 ARID1A RFX5 HNRNPL PPM1G ZNF503 PARP1 JUNB TNRC18 HNRNPUL2 PPIH MBD2 CSTF2T VCP | 1.34e-04 | 1245 | 110 | 18 | int:CEBPA |
| Interaction | PKNOX2 interactions | 1.36e-04 | 48 | 110 | 4 | int:PKNOX2 | |
| Interaction | LAIR2 interactions | 1.47e-04 | 49 | 110 | 4 | int:LAIR2 | |
| Interaction | ZFP64 interactions | 1.47e-04 | 49 | 110 | 4 | int:ZFP64 | |
| Interaction | ARL4D interactions | 1.50e-04 | 146 | 110 | 6 | int:ARL4D | |
| Interaction | MYCN interactions | EPRS1 PRSS1 KRT9 SYNPO2 ZNF326 AKAP8 YBX1 SRP68 PSMD3 HUWE1 GPATCH8 ARID1A HNRNPL PARP1 JUNB HNRNPUL2 DGCR8 PPIH DNAJA1 | 1.51e-04 | 1373 | 110 | 19 | int:MYCN |
| Interaction | MECOM interactions | 1.53e-04 | 358 | 110 | 9 | int:MECOM | |
| Interaction | RNF123 interactions | EPRS1 MYH1 MYH4 SRP68 HUWE1 PHF8 HNRNPL TDRD3 ADRA1D ZBED4 AHNAK ATAD2B DNAJA1 HERC5 | 1.57e-04 | 824 | 110 | 14 | int:RNF123 |
| Interaction | PRMT1 interactions | EPRS1 ZNF326 AKAP8 MAP4 YBX1 DNM1L PSMD3 HUWE1 HNRNPL PARP1 TDRD3 HNRNPUL2 DGCR8 MBD2 VCP | 1.58e-04 | 929 | 110 | 15 | int:PRMT1 |
| Interaction | APOBEC3D interactions | 1.62e-04 | 148 | 110 | 6 | int:APOBEC3D | |
| Interaction | H2BC9 interactions | EPRS1 MYH2 ZNF326 ATRX GPATCH8 PARP1 TDRD3 ZNF469 TNRC18 AHNAK | 1.66e-04 | 446 | 110 | 10 | int:H2BC9 |
| Interaction | FMR1 interactions | EPRS1 AKAP8 YBX1 PSMD3 TACC2 HNRNPL TDRD3 AHNAK TRIM56 DLG4 AGAP2 | 1.69e-04 | 536 | 110 | 11 | int:FMR1 |
| Interaction | PAX6 interactions | 1.80e-04 | 366 | 110 | 9 | int:PAX6 | |
| Interaction | B3GNT2 interactions | EPRS1 MAP4 YBX1 PSMD3 HUWE1 PPM1G PARP1 AHNAK TNKS1BP1 DNAJA1 PBXIP1 | 1.86e-04 | 542 | 110 | 11 | int:B3GNT2 |
| Interaction | HNRNPUL2 interactions | 1.97e-04 | 291 | 110 | 8 | int:HNRNPUL2 | |
| Interaction | HNRNPAB interactions | 2.00e-04 | 371 | 110 | 9 | int:HNRNPAB | |
| Interaction | ANK2 interactions | 2.01e-04 | 98 | 110 | 5 | int:ANK2 | |
| Interaction | HDAC4 interactions | EPRS1 ATRX HUWE1 RFX5 HNRNPL PPM1G PARP1 TDRD3 TESK2 TRIM56 DNAJB5 GOLGA6L9 VCP | 2.09e-04 | 744 | 110 | 13 | int:HDAC4 |
| Interaction | PTPN4 interactions | 2.15e-04 | 54 | 110 | 4 | int:PTPN4 | |
| Interaction | CTCF interactions | ZNF326 ATRX YBX1 SRP68 GPATCH8 ARID1A PARP1 HNRNPUL2 DGCR8 DNAJA1 | 2.17e-04 | 461 | 110 | 10 | int:CTCF |
| Interaction | H3-3A interactions | EPRS1 ERCC6 ATRX CHAF1A ZBTB9 GPATCH8 PHF8 RFX5 PPM1G PARP1 ATAD2B DNAJA1 VCP | 2.23e-04 | 749 | 110 | 13 | int:H3-3A |
| Interaction | OASL interactions | 2.24e-04 | 223 | 110 | 7 | int:OASL | |
| Interaction | U2AF2 interactions | EPRS1 MAP4 YBX1 PSMD3 HUWE1 GPATCH8 HNRNPL PARP1 AHNAK DGCR8 DNAJA1 VCP | 2.29e-04 | 651 | 110 | 12 | int:U2AF2 |
| Interaction | FLII interactions | 2.31e-04 | 298 | 110 | 8 | int:FLII | |
| Interaction | UBA1 interactions | 2.38e-04 | 380 | 110 | 9 | int:UBA1 | |
| Interaction | H1-4 interactions | EPRS1 COL5A2 YBX1 SRP68 TACC2 GPATCH8 PHF8 TNRC18 TRIM56 IRAK4 ALK HERC5 | 2.45e-04 | 656 | 110 | 12 | int:H1-4 |
| Interaction | CHD3 interactions | EPRS1 PRSS1 KRT9 ZNF326 AKAP8 YBX1 CHAF1A SRP68 ARID1A HNRNPL PARP1 HNRNPUL2 MBD2 | 2.47e-04 | 757 | 110 | 13 | int:CHD3 |
| Interaction | MCM2 interactions | MYH1 MYH2 MYH4 AKAP8 ATRX CHAF1A SRP68 PSMD3 HUWE1 HNRNPL PARP1 PRDM8 AHNAK TNKS1BP1 DNAJA1 VCP | 2.53e-04 | 1081 | 110 | 16 | int:MCM2 |
| Interaction | OGG1 interactions | 2.59e-04 | 23 | 110 | 3 | int:OGG1 | |
| Interaction | CDYL2 interactions | 2.59e-04 | 23 | 110 | 3 | int:CDYL2 | |
| Interaction | BAP1 interactions | EPRS1 KRT9 AKAP8 MAP4 YBX1 DNAJB4 SRP68 DNM1L PSMD3 HUWE1 HNRNPL PPM1G PARP1 AHNAK AGFG1 PPIH DNAJA1 VCP | 2.60e-04 | 1314 | 110 | 18 | int:BAP1 |
| Interaction | RNF2 interactions | FOXJ2 EPRS1 ZNF326 AKAP8 YBX1 TRIM41 SRP68 HUWE1 HNRNPL PARP1 HNRNPUL2 TRIM56 PBXIP1 VCP | 2.62e-04 | 866 | 110 | 14 | int:RNF2 |
| Interaction | NPM1 interactions | EPRS1 YBX1 CHAF1A ZBTB9 DNAJB4 SRP68 CCDC80 HUWE1 PPM1G PARP1 JUNB TDRD3 DNAJA1 AGRN ALK VCP HERC5 | 2.69e-04 | 1201 | 110 | 17 | int:NPM1 |
| Interaction | CEBPB interactions | EPRS1 ZNF326 AKAP8 MAP4 YBX1 SRP68 PSMD3 GPATCH8 HNRNPL SBNO2 PPM1G PARP1 JUNB CD99 AHNAK AGFG1 MBD2 DNAJA1 CSTF2T | 2.85e-04 | 1443 | 110 | 19 | int:CEBPB |
| Interaction | MKRN1 interactions | 2.92e-04 | 165 | 110 | 6 | int:MKRN1 | |
| Interaction | KIAA0319 interactions | 2.92e-04 | 5 | 110 | 2 | int:KIAA0319 | |
| Interaction | BTRC interactions | AKAP8 YBX1 GPATCH8 PHF8 ARID1A HNRNPL PPM1G PARP1 HNRNPUL2 TNKS1BP1 SLC39A7 VCP HERC5 | 3.10e-04 | 775 | 110 | 13 | int:BTRC |
| Interaction | ATXN2 interactions | 3.15e-04 | 312 | 110 | 8 | int:ATXN2 | |
| Interaction | AR interactions | ZNF326 ATRX ZBTB9 PSMD3 HUWE1 ARID1A RFX5 DDC HNRNPL PARP1 TNRC18 HNRNPUL2 MBD2 DNAJA1 VCP | 3.20e-04 | 992 | 110 | 15 | int:AR |
| Interaction | CCDC185 interactions | 3.24e-04 | 60 | 110 | 4 | int:CCDC185 | |
| Interaction | ACE2 interactions | EPRS1 PRSS1 KRT9 ZNF326 MAP4 YBX1 CHAF1A TRIOBP PSMD3 HNRNPL PARP1 ZNHIT6 CD99 AGFG1 AGRN VCP | 3.26e-04 | 1106 | 110 | 16 | int:ACE2 |
| Interaction | RC3H1 interactions | KRT9 ZNF326 YBX1 SRP68 HNRNPL PARP1 TDRD3 HNRNPUL2 TNKS1BP1 DNAJA1 VCP HERC5 | 3.26e-04 | 677 | 110 | 12 | int:RC3H1 |
| Interaction | BLM interactions | 3.41e-04 | 239 | 110 | 7 | int:BLM | |
| Interaction | FGF11 interactions | 3.42e-04 | 170 | 110 | 6 | int:FGF11 | |
| Interaction | POU5F1 interactions | KRT9 AKAP8 YBX1 SRP68 PSMD3 HUWE1 ARID1A HNRNPL PARP1 AHNAK DNAJA1 | 3.51e-04 | 584 | 110 | 11 | int:POU5F1 |
| Interaction | EIF3K interactions | 3.53e-04 | 171 | 110 | 6 | int:EIF3K | |
| Interaction | GLDC interactions | 3.81e-04 | 321 | 110 | 8 | int:GLDC | |
| Interaction | BARD1 interactions | 3.97e-04 | 323 | 110 | 8 | int:BARD1 | |
| Interaction | RNF113A interactions | EPRS1 AKAP8 MAP4 YBX1 SRP68 HNRNPL PPM1G TNRC18 HNRNPUL2 TRIM56 MBD2 DNAJA1 | 3.97e-04 | 692 | 110 | 12 | int:RNF113A |
| Interaction | H2AC8 interactions | 4.25e-04 | 177 | 110 | 6 | int:H2AC8 | |
| Interaction | DPYSL2 interactions | 4.31e-04 | 327 | 110 | 8 | int:DPYSL2 | |
| Interaction | PABPC1 interactions | EPRS1 MAP4 YBX1 CHAF1A SRP68 DNM1L PSMD3 HNRNPL TDRD3 AHNAK AGRN VCP | 4.35e-04 | 699 | 110 | 12 | int:PABPC1 |
| Interaction | CREBBP interactions | ATRX CHAF1A TACC2 HUWE1 ARID1A HNRNPL PARP1 JUNB PBX1 MBD2 HERC5 | 4.35e-04 | 599 | 110 | 11 | int:CREBBP |
| Interaction | ZNF595 interactions | 4.37e-04 | 6 | 110 | 2 | int:ZNF595 | |
| Interaction | SHISA9 interactions | 4.37e-04 | 6 | 110 | 2 | int:SHISA9 | |
| Interaction | ASAH2 interactions | 4.37e-04 | 6 | 110 | 2 | int:ASAH2 | |
| Interaction | GRB2 interactions | KRT9 YBX1 DNAJB4 HUWE1 SH2B1 PARP1 MYOZ1 AHNAK PPIH ALK PBXIP1 CSTF2T VCP | 4.50e-04 | 806 | 110 | 13 | int:GRB2 |
| Cytoband | 17p13.1 | 1.11e-05 | 118 | 112 | 5 | 17p13.1 | |
| Cytoband | 9p13.3 | 3.57e-05 | 75 | 112 | 4 | 9p13.3 | |
| Cytoband | 12q12 | 2.12e-04 | 47 | 112 | 3 | 12q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p23 | 5.04e-04 | 149 | 112 | 4 | chr2p23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q12 | 5.05e-04 | 63 | 112 | 3 | chr12q12 | |
| Cytoband | Yp11.3 | 6.92e-04 | 16 | 112 | 2 | Yp11.3 | |
| Cytoband | 1p22.3 | 1.32e-03 | 22 | 112 | 2 | 1p22.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p13 | 1.64e-03 | 346 | 112 | 5 | chr17p13 | |
| Cytoband | 12q14.1 | 2.14e-03 | 28 | 112 | 2 | 12q14.1 | |
| GeneFamily | Collagens | 1.78e-06 | 46 | 80 | 5 | 490 | |
| GeneFamily | Myosin heavy chains | 3.65e-05 | 15 | 80 | 3 | 1098 | |
| GeneFamily | DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing | 1.33e-03 | 49 | 80 | 3 | 584 | |
| Coexpression | NABA_COLLAGENS | 1.05e-06 | 43 | 111 | 5 | MM17060 | |
| Coexpression | NABA_COLLAGENS | 1.18e-06 | 44 | 111 | 5 | M3005 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | COL2A1 FOXJ2 SYNPO2 COL9A3 ZNF326 ATRX DNM1L ARID1A PPIC INPP4B COL24A1 TESK2 NRK ATAD2B MBD2 | 7.65e-06 | 744 | 111 | 15 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.23e-11 | 197 | 111 | 10 | 05e303fff86db31f7b742324c64980eb2b9cff9a | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.60e-11 | 198 | 111 | 10 | cfe2d52b19a1b4c2c2076fa1d5a69baf21a49623 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.41e-07 | 197 | 111 | 7 | 5f6fce382f273e789ffbb75b63e9b4e87519918e | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.63e-07 | 198 | 111 | 7 | d9ffc6589ed510ffa60c591f2a0fe123210f1455 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-early|World / Primary Cells by Cluster | 6.86e-07 | 199 | 111 | 7 | 549391e7a4285da1c0e366654530bcf1cd33fbae | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.86e-07 | 199 | 111 | 7 | bfc157be6e9f84739848eb19b718de5b17f3fa88 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-early-40|World / Primary Cells by Cluster | 6.86e-07 | 199 | 111 | 7 | 23625d757173bdd35a51c7919ff4b588168d2553 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.86e-07 | 199 | 111 | 7 | bb201deb281619113edcd1de2af2d3eb21b967b8 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.86e-07 | 199 | 111 | 7 | 3d8c76e3d05acf72a35ca755b51579fc3ae63562 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.29e-06 | 162 | 111 | 6 | 810881210e015c788814e4fe8d7a24c929cf2621 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.27e-06 | 186 | 111 | 6 | c116cc9f41971622264434ebe29d18e719b0ae19 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.50e-06 | 187 | 111 | 6 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.50e-06 | 187 | 111 | 6 | 13731298bc562ec29582f5da1b4c97261284f6f1 | |
| ToppCell | E12.5-Mesenchymal|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.73e-06 | 188 | 111 | 6 | 9778dadc2bd7ded3a723e717d1c8cd3160e99c6c | |
| ToppCell | MatrixFB-Fibroblast-C|MatrixFB / shred on cell class and cell subclass (v4) | 8.21e-06 | 190 | 111 | 6 | d0106f7a21292f0b96ce4337ec3efbb1bd78dd0a | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Radial_glial-RGCs_early_2|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 8.46e-06 | 191 | 111 | 6 | 06107849463a1ccb78a5ccd3ae31619ef6bedda3 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Adventitial_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 9.80e-06 | 196 | 111 | 6 | eed9fe83ffc1f79493b70778962a671dd9f481e0 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.01e-05 | 197 | 111 | 6 | 2744cc94883c5d0424677cf5093bbab622933e9b | |
| ToppCell | 11.5-Airway-Mesenchymal-Mesenchyme_SERPINF1-high|Airway / Age, Tissue, Lineage and Cell class | 1.01e-05 | 197 | 111 | 6 | 9a053a32ff9c3a85ef9a3382453acd619cc48546 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.04e-05 | 198 | 111 | 6 | 1f956e369e00d37835095a001db4b62a79014532 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.04e-05 | 198 | 111 | 6 | dc6fbad0ecdd057189f71afcdb6aca25207314a3 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-05 | 198 | 111 | 6 | 9541d68a1a6247dbd7161a62644eea6527c2c8ff | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-05 | 199 | 111 | 6 | 103f657132e830a0e5efeb745afb4b77c208a1fa | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Adventitial_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.07e-05 | 199 | 111 | 6 | 8de6d7b2067b22cb9b5f01aa56a3803aebc4406d | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-05 | 199 | 111 | 6 | 9846d6a31635fde759d55674631c11ab9270a603 | |
| ToppCell | distal-1-mesenchymal-Lipofibroblast|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.07e-05 | 199 | 111 | 6 | a8293db3c42a8d30897858b49aae7acfc18663ba | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l28|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.10e-05 | 200 | 111 | 6 | d254f6634895486f81d7a8b6f006fbc2679eaa5b | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Hsd11b1_Endou|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.76e-05 | 158 | 111 | 5 | c8af8964a140acb2987e3b4906d72c546108d229 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-Trm_Th1/Th17|bone_marrow / Manually curated celltypes from each tissue | 5.52e-05 | 163 | 111 | 5 | 4d1fd0b1246833723b938eca0cb246e937380e12 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.85e-05 | 165 | 111 | 5 | e24621c8d4dbafb407033d832fe9337f13feae34 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Papillary_Renal_Cell_Carcinoma-7|TCGA-Kidney / Sample_Type by Project: Shred V9 | 6.02e-05 | 166 | 111 | 5 | b545de32578047c9ca422354b8992f2d9c9e1cc7 | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 6.55e-05 | 169 | 111 | 5 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | metastatic_Brain-Fibroblasts-Undetermined|metastatic_Brain / Location, Cell class and cell subclass | 8.15e-05 | 177 | 111 | 5 | 54f39be5d90363cfd44dea1a96ae06d3143aa795 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c08-GZMK-FOS_h|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.59e-05 | 179 | 111 | 5 | b0585a8e596c3d8e434af943e65207fa5877600d | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.29e-05 | 182 | 111 | 5 | 4a85429d365c4b2d73fc921f261b4b7635ac40bd | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.29e-05 | 182 | 111 | 5 | 53213af34af3337f5edc734d3b7b79e4349eac0d | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular-Interstitial_macrophage_perivascular_L.1.2.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.29e-05 | 182 | 111 | 5 | 7909089ed6325c44edd6f9b7e8b1d542398222ea | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.29e-05 | 182 | 111 | 5 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | Mesenchymal_cells-Osteoblasts|Mesenchymal_cells / Lineage and Cell class | 9.53e-05 | 183 | 111 | 5 | d6b52d52fe9a7a6c798947f05420d79fe12e4662 | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.78e-05 | 184 | 111 | 5 | 01257e5c12e38b849fd3d9496c43ded666249ba5 | |
| ToppCell | Mesenchymal_cells-Chondrocytes|World / Lineage and Cell class | 9.78e-05 | 184 | 111 | 5 | 1e03f9f08de5ad4d45388a95afad9f23ff0d0e28 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 9.78e-05 | 184 | 111 | 5 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.00e-04 | 185 | 111 | 5 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.00e-04 | 185 | 111 | 5 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.00e-04 | 185 | 111 | 5 | 1ac6a32cc56d5d819649bdd99518e2ead0eead4c | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-chondrocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.03e-04 | 186 | 111 | 5 | 80a0a42ca8585cdb1dda57a18c254316a126ee64 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-04 | 186 | 111 | 5 | 310d16f4e5cffee3ea6d7635508c513a3b92131e | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.05e-04 | 187 | 111 | 5 | ed7ab4cf4629d96dad5c74d536fc428d0a8d4eb9 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.05e-04 | 187 | 111 | 5 | db771e952f71a12886c2dbc77c6cd07054ef809a | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 188 | 111 | 5 | 0aa8747c2931b0c91f6d78bb2db8fd8ede6dd559 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.08e-04 | 188 | 111 | 5 | 0501a8aa850bd2e347020abd1cac4d8075738189 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.08e-04 | 188 | 111 | 5 | 433a25fe52914e07e7ba695881f9bcca2d9467ff | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.08e-04 | 188 | 111 | 5 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-chondrocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.08e-04 | 188 | 111 | 5 | 5a89587ee6f2b4dc14244bd88bb31efb81c50dbe | |
| ToppCell | Mesenchymal_cells-Osteoblasts|World / Lineage and Cell class | 1.08e-04 | 188 | 111 | 5 | 89f7f5a51be7e046a63e2413f86c521ae4b6718f | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-Trm_Th1/Th17|Lung / Manually curated celltypes from each tissue | 1.11e-04 | 189 | 111 | 5 | f43960506ed3e699e910ec7711c1113e2e9b80d1 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.11e-04 | 189 | 111 | 5 | f7e2ee5047792ab9ef6472fa88e2d193cdea6fa0 | |
| ToppCell | droplet-Lung-immune-endo-depleted|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 189 | 111 | 5 | c3fb363bb0156ffb3367c200f548faebda64ab4a | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 189 | 111 | 5 | 2a2953f6b1b7d070d739dcaf7285fce6e097d9e4 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.11e-04 | 189 | 111 | 5 | f0aaf2994d319a39877d2845eaab9f166adead4e | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.11e-04 | 189 | 111 | 5 | dc5164591dea45b420798b94dda211be03daa70c | |
| ToppCell | droplet-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.11e-04 | 189 | 111 | 5 | 5a636e952da9b1fd26aa17f7b129054f2da322b5 | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.14e-04 | 190 | 111 | 5 | 1196b8ea2c44c7c80f5ee589dd517e6a413f2077 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 190 | 111 | 5 | 9cd147a174017ebda23cc47b6d4552d898acd092 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.16e-04 | 191 | 111 | 5 | 44a9a6768084dafc641ad455b65862bfd4cc0cb9 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 191 | 111 | 5 | a261f0738d974784bbdd60f23092bfbcca464459 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 191 | 111 | 5 | 6594398cc8151c73696391a43ac110c10283dab1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.16e-04 | 191 | 111 | 5 | 7b386512284dfaa0e95358b28ee82632ee965e64 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-04 | 191 | 111 | 5 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.16e-04 | 191 | 111 | 5 | 44b1f62fdee03b157fe545f2ae6ff84f8929a8ac | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 191 | 111 | 5 | f932980baa032748857cb367a55c37dd975c693e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.16e-04 | 191 | 111 | 5 | fa50a3c7ff86e1ee07100da1ace0b0fa1b0ab26b | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.16e-04 | 191 | 111 | 5 | 4a29b7d5cd10e9077699d3aa76e3db6c4d5a0cf6 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.19e-04 | 192 | 111 | 5 | f053b89bfd6048c227667ff01c38df7c51d8a496 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 192 | 111 | 5 | 5890076929598e88fe9d59a4e4e858b446746ce9 | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 192 | 111 | 5 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.22e-04 | 193 | 111 | 5 | 9a2c1711dec9dd8c8313bcf25bb888ac8e86c3f3 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.22e-04 | 193 | 111 | 5 | ec81c1afdae2e0433a22c8c1fa1c6232526ff7e7 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 193 | 111 | 5 | 4a8c97ff2dffc5c06351d1cb107e21e58250aa55 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.22e-04 | 193 | 111 | 5 | cd45118ced91b10baed3b1068d4673ec99824b86 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 193 | 111 | 5 | d5f6d6e2c36d4e80af4d39cdfc0b18df295a587b | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.22e-04 | 193 | 111 | 5 | adc9fc94f9ec686a417d08c0b8b7b7ab687afec0 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.22e-04 | 193 | 111 | 5 | 7c7aa5e2124830d0fa1df11b6413ec6cf780aad0 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 193 | 111 | 5 | 8084fa0ce61f1f4a728423b6b81df04eaa5af5b6 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.22e-04 | 193 | 111 | 5 | 30481fb01c7acf85beae10213f038da86bed6777 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.25e-04 | 194 | 111 | 5 | 69362e13158033de44f90f3773db6c0f27de8cb3 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 194 | 111 | 5 | fb234d97191c95b7880280c6e4ed5df124ffb0e1 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.25e-04 | 194 | 111 | 5 | 811b382ec3da06a6bda7360abc8b633f96b2019e | |
| ToppCell | T/NK_cells-Regulatory_T_cell|T/NK_cells / Lineage and Cell class | 1.25e-04 | 194 | 111 | 5 | 22843d03366ead435a0cb35092d6f734c225024c | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 194 | 111 | 5 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | 18-Distal-Mesenchymal-Mesenchyme_SERPINF1-high|Distal / Age, Tissue, Lineage and Cell class | 1.28e-04 | 195 | 111 | 5 | f86737bff21d81673238813df61a15cfe88d0b15 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 195 | 111 | 5 | 126f46dd15dddcf5701144718bb8ba1ce84b2d1d | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.28e-04 | 195 | 111 | 5 | 56e7cd980f8fc2dae842e6a7bd919d4b41cebbbb | |
| ToppCell | BLOOD--(1)_T_cell-(1)_EM_T_cells|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.28e-04 | 195 | 111 | 5 | 4b8831ed8fb73579f49604eeda8a3b2344e69f0e | |
| ToppCell | BLOOD--(1)_Activated_T_cells| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.28e-04 | 195 | 111 | 5 | 45515d5da8a8c8242eb70a1bea24fe44eca5407b | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.28e-04 | 195 | 111 | 5 | a28a504c69bc4dda7de023e1b4ea4f62390b158e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.31e-04 | 196 | 111 | 5 | 525d6c8a277364e624e7cc586275f8a891436b57 | |
| ToppCell | Mesenchymal_cells-Fibro/Chondro_p.|World / Lineage and Cell class | 1.31e-04 | 196 | 111 | 5 | ddc168849e0e97005a111be004463bb72d433853 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 196 | 111 | 5 | 81900dcc9451ff6606ec940c16b559d73247590e | |
| ToppCell | (2)_NK/T-(231)_CD4+/CD45RO+_Memory_T_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 1.31e-04 | 196 | 111 | 5 | 5267acead12207f238d9afa3eef8ac1168b47082 | |
| Drug | Madecassol | 2.81e-06 | 46 | 110 | 5 | CID000108062 | |
| Drug | Ampyrone [83-07-8]; Down 200; 19.6uM; PC3; HT_HG-U133A | 4.02e-06 | 190 | 110 | 8 | 4507_DN | |
| Drug | radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 4.18e-06 | 191 | 110 | 8 | 1057_DN | |
| Drug | Gliquidone [33342-05-1]; Down 200; 7.6uM; PC3; HT_HG-U133A | 5.25e-06 | 197 | 110 | 8 | 7301_DN | |
| Drug | sodium dodecyl sulfate | 5.29e-06 | 91 | 110 | 6 | CID000008778 | |
| Drug | candesartan cilexetil | 6.76e-06 | 145 | 110 | 7 | CID000002540 | |
| Drug | PPACK | 1.84e-05 | 113 | 110 | 6 | CID003036757 | |
| Drug | chrysene | MYH1 MYH4 YBX1 DNAJB4 PSMD3 TACC2 DDC JUNB TDRD3 MYOZ1 CD99 AHNAK DNAJB5 PBX1 DNAJA1 | 1.94e-05 | 871 | 110 | 15 | ctd:C031180 |
| Drug | malotilate | 2.43e-05 | 71 | 110 | 5 | CID000004006 | |
| Drug | GK-101 | 2.70e-05 | 36 | 110 | 4 | CID000161853 | |
| Drug | H 77 | 3.03e-05 | 13 | 110 | 3 | CID000133836 | |
| Drug | pioglitazone HCl; Down 200; 10uM; PC3; HT_HG-U133A | 3.06e-05 | 183 | 110 | 7 | 7088_DN | |
| Drug | AC1MRIIV | 3.72e-05 | 39 | 110 | 4 | CID003518584 | |
| Drug | Diphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 4.02e-05 | 191 | 110 | 7 | 6020_DN | |
| Drug | Ursolic acid [77-52-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 4.59e-05 | 195 | 110 | 7 | 2230_DN | |
| Drug | Hydroquinine hydrobromide hydrate [304695-81-6]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 4.59e-05 | 195 | 110 | 7 | 2767_UP | |
| Drug | CAY10397; Down 200; 10uM; PC3; HT_HG-U133A | 4.74e-05 | 196 | 110 | 7 | 7087_DN | |
| Drug | Sulfabenzamide [127-71-9]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 4.90e-05 | 197 | 110 | 7 | 2814_DN | |
| Drug | S(-)Eticlopride hydrochloride [97612-24-3]; Down 200; 10.6uM; HL60; HT_HG-U133A | 4.90e-05 | 197 | 110 | 7 | 3056_DN | |
| Drug | fast white | 5.01e-05 | 42 | 110 | 4 | CID000024008 | |
| Drug | Deltaline [6836-11-9]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 5.05e-05 | 198 | 110 | 7 | 6026_UP | |
| Drug | Butamben [94-25-7]; Up 200; 20.6uM; MCF7; HT_HG-U133A | 5.22e-05 | 199 | 110 | 7 | 6093_UP | |
| Drug | Clindamycin hydrochloride [21462-39-5]; Down 200; 8.6uM; PC3; HT_HG-U133A | 5.22e-05 | 199 | 110 | 7 | 2057_DN | |
| Drug | Procaine hydrochloride [51-05-8]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 5.39e-05 | 200 | 110 | 7 | 1674_UP | |
| Drug | 1zd2 | 6.60e-05 | 45 | 110 | 4 | CID004149241 | |
| Drug | N-allylglycine | 6.92e-05 | 3 | 110 | 2 | CID000076651 | |
| Drug | N-acetyl-L-norvaline methyl ester | 6.92e-05 | 3 | 110 | 2 | CID000150916 | |
| Drug | YAKR-CK | 6.92e-05 | 3 | 110 | 2 | CID005487256 | |
| Drug | 2 alpha-bromoacetoxyprogesterone | 6.92e-05 | 3 | 110 | 2 | CID000135256 | |
| Drug | methyl lignocerate | 6.92e-05 | 3 | 110 | 2 | CID000075546 | |
| Drug | GB-107 | 6.92e-05 | 3 | 110 | 2 | CID000056813 | |
| Drug | mitorubrinic acid | 6.92e-05 | 3 | 110 | 2 | CID000379537 | |
| Drug | ASA-PE | 6.92e-05 | 3 | 110 | 2 | CID003037809 | |
| Drug | schizopeptin 791 | 6.92e-05 | 3 | 110 | 2 | CID000636821 | |
| Drug | Lapg-nh2 | 6.92e-05 | 3 | 110 | 2 | CID003082486 | |
| Drug | Methotrexate-polylysine | 6.92e-05 | 3 | 110 | 2 | CID000163214 | |
| Drug | methyl octanesulfonate | 6.92e-05 | 3 | 110 | 2 | CID000165858 | |
| Drug | 3HFGB | 6.92e-05 | 3 | 110 | 2 | CID000126268 | |
| Drug | 4-chlorobenzenediazonium hexafluorophosphate | 6.92e-05 | 3 | 110 | 2 | CID002723983 | |
| Drug | 10-(carboxyethyl)flavin | 6.92e-05 | 3 | 110 | 2 | CID003082170 | |
| Drug | Z-Lys-CH2Cl | 6.92e-05 | 3 | 110 | 2 | CID000127335 | |
| Drug | Poly Adenosine Diphosphate Ribose | 6.92e-05 | 3 | 110 | 2 | ctd:D011064 | |
| Drug | 2,6-dimethyl-3-pyridinol | 6.92e-05 | 3 | 110 | 2 | CID000070732 | |
| Drug | N-phosphopyridoxyl-L-serine | 6.92e-05 | 3 | 110 | 2 | CID000195946 | |
| Drug | Z-Arg-OH | 6.92e-05 | 3 | 110 | 2 | CID000071055 | |
| Drug | p-amidinophenylpyruvate | 6.92e-05 | 3 | 110 | 2 | CID000444106 | |
| Drug | v 1194 | 6.92e-05 | 3 | 110 | 2 | CID000074702 | |
| Drug | L-TAPA | 6.92e-05 | 3 | 110 | 2 | CID000193734 | |
| Drug | S-(+)-Methoprene | 7.20e-05 | 46 | 110 | 4 | CID000038532 | |
| Drug | AC1L1GXW | 9.37e-05 | 94 | 110 | 5 | CID000003891 | |
| Drug | d-indobufen | 1.00e-04 | 50 | 110 | 4 | CID000044562 | |
| Drug | b-Ti | 1.00e-04 | 19 | 110 | 3 | CID011840927 | |
| Drug | 1-phenylethanol | 1.08e-04 | 51 | 110 | 4 | CID000007409 | |
| Drug | ridogrel | 1.17e-04 | 52 | 110 | 4 | CID005362391 | |
| Drug | L-Proline | 1.18e-04 | 20 | 110 | 3 | DB00172 | |
| Drug | NSC49633 | 1.26e-04 | 53 | 110 | 4 | CID000023340 | |
| Drug | L-lysyl-L-lysyl-L-lysine | 1.38e-04 | 162 | 110 | 6 | CID000072363 | |
| Drug | 4-Amino-3-nitrobenzoic acid | 1.38e-04 | 4 | 110 | 2 | CID000074115 | |
| Drug | 4-ethylpiperidine | 1.38e-04 | 4 | 110 | 2 | CID000076704 | |
| Drug | torquatone | 1.38e-04 | 4 | 110 | 2 | CID000256516 | |
| Drug | mGBSOM | 1.38e-04 | 4 | 110 | 2 | CID003080804 | |
| Drug | Ba-O | 1.38e-04 | 4 | 110 | 2 | CID000002280 | |
| Drug | NSC-13568 | 1.38e-04 | 4 | 110 | 2 | CID000224783 | |
| Drug | xylaric acid | 1.38e-04 | 4 | 110 | 2 | CID003084064 | |
| Drug | AC1LAOUV | 1.38e-04 | 4 | 110 | 2 | CID000492408 | |
| Drug | 5'-S-propynyl-5'-thioadenosine | 1.38e-04 | 4 | 110 | 2 | CID000492409 | |
| Drug | AC1Q5JO7 | 1.38e-04 | 4 | 110 | 2 | CID000128324 | |
| Drug | Dsdgk | 1.38e-04 | 4 | 110 | 2 | CID000130454 | |
| Drug | NSC-333492 | 1.38e-04 | 4 | 110 | 2 | CID000333256 | |
| Drug | NSC-45351 | 1.38e-04 | 4 | 110 | 2 | CID000018046 | |
| Drug | indomethacin-NHS | 1.38e-04 | 4 | 110 | 2 | CID000128571 | |
| Drug | bromomesaconic acid | 1.38e-04 | 4 | 110 | 2 | CID006449799 | |
| Drug | N-carbobenzoxyglycine vinyl ester | 1.38e-04 | 4 | 110 | 2 | CID000047309 | |
| Drug | chondroitin sulfate | 1.80e-04 | 413 | 110 | 9 | CID000024766 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.85e-04 | 171 | 110 | 6 | 5441_DN | |
| Drug | AC1L1C2F | 1.96e-04 | 110 | 110 | 5 | CID000001711 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.23e-04 | 177 | 110 | 6 | 3227_DN | |
| Drug | Sr 42128 | 2.29e-04 | 5 | 110 | 2 | CID005487043 | |
| Drug | 4-TGPAP | 2.29e-04 | 5 | 110 | 2 | CID000132086 | |
| Drug | PTA-Arg | 2.29e-04 | 5 | 110 | 2 | CID000194378 | |
| Drug | I 333 | 2.29e-04 | 5 | 110 | 2 | CID000533915 | |
| Drug | N-(5'-carboxypentyl)-1-deoxynojirimycin | 2.29e-04 | 5 | 110 | 2 | CID000133177 | |
| Drug | propynyl benzoate | 2.29e-04 | 5 | 110 | 2 | CID000196666 | |
| Drug | M 93 | 2.29e-04 | 5 | 110 | 2 | CID006444952 | |
| Drug | Ag-B | 2.29e-04 | 5 | 110 | 2 | CID000004286 | |
| Drug | 2,6-diphenoxypyridine | 2.29e-04 | 5 | 110 | 2 | CID000824772 | |
| Drug | AC1L3UIZ | 2.29e-04 | 5 | 110 | 2 | CID000147121 | |
| Drug | Ile-Phe-Lys-CH2Cl | 2.29e-04 | 5 | 110 | 2 | CID000124393 | |
| Drug | rho-guanidinobenzoate | 2.29e-04 | 5 | 110 | 2 | CID005311472 | |
| Drug | PTA-GPA | 2.29e-04 | 5 | 110 | 2 | CID000139330 | |
| Drug | 6-amidinoindole | 2.29e-04 | 5 | 110 | 2 | CID003018291 | |
| Drug | beta-Neuroprotectin | 2.29e-04 | 5 | 110 | 2 | CID005748443 | |
| Drug | Meebdp | 2.29e-04 | 5 | 110 | 2 | CID000132560 | |
| Drug | AC1LAKND | 2.32e-04 | 62 | 110 | 4 | CID000470146 | |
| Drug | trichostatin A; Down 200; 0.1uM; MCF7; HG-U133A | 2.37e-04 | 179 | 110 | 6 | 331_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.44e-04 | 180 | 110 | 6 | 5511_DN | |
| Drug | corilagin | 2.78e-04 | 65 | 110 | 4 | CID000073568 | |
| Drug | hyaluronan | 2.93e-04 | 263 | 110 | 7 | CID000024759 | |
| Drug | cupric oxide | COL5A2 ATRX MAP4 YBX1 TRIOBP CCDC80 HNRNPL NFE2L3 AHNAK DNAJA1 | 3.04e-04 | 543 | 110 | 10 | ctd:C030973 |
| Drug | Dipyrone [5907-38-0]; Down 200; 12uM; PC3; HT_HG-U133A | 3.08e-04 | 188 | 110 | 6 | 4310_DN | |
| Disease | distal myopathy (implicated_via_orthology) | 6.52e-08 | 12 | 102 | 4 | DOID:11720 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 4.73e-06 | 10 | 102 | 3 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 4.73e-06 | 10 | 102 | 3 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 4.73e-06 | 10 | 102 | 3 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 4.73e-06 | 10 | 102 | 3 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 4.73e-06 | 10 | 102 | 3 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 4.73e-06 | 10 | 102 | 3 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 4.73e-06 | 10 | 102 | 3 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 4.73e-06 | 10 | 102 | 3 | DOID:0080326 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 8.63e-06 | 12 | 102 | 3 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 1.12e-05 | 13 | 102 | 3 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 1.77e-05 | 15 | 102 | 3 | DOID:0050646 (implicated_via_orthology) | |
| Disease | Stickler syndrome (is_implicated_in) | 7.07e-05 | 4 | 102 | 2 | DOID:0080046 (is_implicated_in) | |
| Disease | autosomal dominant limb-girdle muscular dystrophy type 1 (implicated_via_orthology) | 7.07e-05 | 4 | 102 | 2 | DOID:0110305 (implicated_via_orthology) | |
| Disease | congenital myopathy 21 (implicated_via_orthology) | 7.07e-05 | 4 | 102 | 2 | DOID:0081353 (implicated_via_orthology) | |
| Disease | PANCREATITIS, HEREDITARY | 1.18e-04 | 5 | 102 | 2 | 167800 | |
| Disease | Stickler syndrome, type 1 | 1.18e-04 | 5 | 102 | 2 | C2020284 | |
| Disease | Hereditary pancreatitis | 1.18e-04 | 5 | 102 | 2 | cv:C0238339 | |
| Disease | Autosomal Dominant Hereditary Pancreatitis | 1.18e-04 | 5 | 102 | 2 | C4080064 | |
| Disease | Severe Congenital Microcephaly | 1.68e-04 | 31 | 102 | 3 | C3853041 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 1.74e-04 | 80 | 102 | 4 | DOID:12930 (implicated_via_orthology) | |
| Disease | inclusion body myositis (is_implicated_in) | 1.76e-04 | 6 | 102 | 2 | DOID:3429 (is_implicated_in) | |
| Disease | Microlissencephaly | 2.03e-04 | 33 | 102 | 3 | C1956147 | |
| Disease | Hereditary pancreatitis | 2.46e-04 | 7 | 102 | 2 | C0238339 | |
| Disease | syndromic X-linked intellectual disability (implicated_via_orthology) | 3.27e-04 | 8 | 102 | 2 | DOID:0060309 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | MYH1 ERCC6 AKAP8 YBX1 TACC2 ARID1A INPP4B HNRNPL PARP1 ALK AGAP2 ZNF646 | 3.38e-04 | 1074 | 102 | 12 | C0006142 |
| Disease | Pancreatitis, Chronic | 4.19e-04 | 9 | 102 | 2 | C0149521 | |
| Disease | neuroblastoma (is_implicated_in) | 5.23e-04 | 10 | 102 | 2 | DOID:769 (is_implicated_in) | |
| Disease | Neuroblastoma | 5.82e-04 | 47 | 102 | 3 | C0027819 | |
| Disease | myopathy (implicated_via_orthology) | 6.20e-04 | 48 | 102 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | Behavior Disorders | 7.64e-04 | 12 | 102 | 2 | C0004930 | |
| Disease | Mental disorders | 7.64e-04 | 12 | 102 | 2 | C0004936 | |
| Disease | Mouth Diseases | 7.64e-04 | 12 | 102 | 2 | C0026636 | |
| Disease | Mental Disorders, Severe | 7.64e-04 | 12 | 102 | 2 | C4046029 | |
| Disease | Diagnosis, Psychiatric | 7.64e-04 | 12 | 102 | 2 | C0376338 | |
| Disease | Parkinson disease | 8.88e-04 | 321 | 102 | 6 | MONDO_0005180 | |
| Disease | Connective Tissue Diseases | 9.00e-04 | 13 | 102 | 2 | C0009782 | |
| Disease | African Burkitt's lymphoma | 1.21e-03 | 15 | 102 | 2 | C0343640 | |
| Disease | head and neck squamous cell carcinoma (is_implicated_in) | 1.21e-03 | 15 | 102 | 2 | DOID:5520 (is_implicated_in) | |
| Disease | Burkitt Leukemia | 1.21e-03 | 15 | 102 | 2 | C4721444 | |
| Disease | Myasthenic Syndromes, Congenital, Slow Channel | 1.38e-03 | 16 | 102 | 2 | C0751885 | |
| Disease | Congenital Myasthenic Syndromes, Postsynaptic | 1.56e-03 | 17 | 102 | 2 | C0751883 | |
| Disease | Microcephaly | 1.64e-03 | 67 | 102 | 3 | C0025958 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.76e-03 | 148 | 102 | 4 | C0279702 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 1.93e-03 | 71 | 102 | 3 | DOID:0050700 (implicated_via_orthology) | |
| Disease | Congenital Myasthenic Syndromes, Presynaptic | 1.95e-03 | 19 | 102 | 2 | C0751884 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 1.95e-03 | 19 | 102 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | Craniofacial Abnormalities | 2.14e-03 | 156 | 102 | 4 | C0376634 | |
| Disease | Multiple Epiphyseal Dysplasia | 2.16e-03 | 20 | 102 | 2 | C0026760 | |
| Disease | Infiltrating duct carcinoma of female breast | 2.38e-03 | 21 | 102 | 2 | C3165106 | |
| Disease | Disproportionate short stature | 2.44e-03 | 77 | 102 | 3 | C0878659 | |
| Disease | Myasthenic Syndromes, Congenital | 3.11e-03 | 24 | 102 | 2 | C0751882 | |
| Disease | Pseudoaphakia | 3.11e-03 | 24 | 102 | 2 | C0524524 | |
| Disease | Lens Opacities | 3.11e-03 | 24 | 102 | 2 | C1510497 | |
| Disease | lung adenocarcinoma (is_marker_for) | 3.23e-03 | 85 | 102 | 3 | DOID:3910 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GTSEGGAGSLGKQEG | 151 | Q8N6Y0 | |
| DGEGVGGGASALTSG | 31 | Q8NDL9 | |
| QYGEEGLKTGGGTSG | 66 | O75953 | |
| GGKHGGGDQGIQTGL | 181 | A8MXV6 | |
| GNQGDRGDKGAAGAG | 596 | Q14050 | |
| ETKNVASGGGGVGDG | 566 | O00429 | |
| GSGGGGEGIQDRESS | 111 | O43823 | |
| LSGDQEASGGGSGGL | 1071 | O00468 | |
| LSGVGGKMQVGGDGV | 5331 | Q09666 | |
| STSGGVGAGAGARGK | 251 | Q99490 | |
| ADGVSGGEGKGGSDG | 96 | P14209 | |
| AASGAGGGVGVDTGK | 931 | Q13111 | |
| GSVGDGVGIGGESAD | 166 | Q8WYQ5 | |
| KAGEGGGVIQGSASE | 136 | P20711 | |
| KGGEQAIKEGGAGGG | 66 | P31689 | |
| TGGGAAGAGGSEAKL | 176 | Q96SC8 | |
| QGVCGTVGSGIKNGG | 766 | Q02487 | |
| AASVGEGGGGGRKVG | 436 | Q03468 | |
| GGQAGGGSKVGPEDQ | 1406 | Q5H9R4 | |
| VEGQVVAEGNDGGGG | 286 | Q76M96 | |
| AAGVKGDRGETGAVG | 1051 | P02458 | |
| GGDFVNGDGTGVASI | 76 | O43447 | |
| AQGQGDGTVSKGGRG | 531 | P48382 | |
| AGGVTGKGQDGIGSK | 91 | P09874 | |
| KELQDGAESNGGGGG | 71 | O14497 | |
| AASVGEGGGGGRKVG | 436 | P0DP91 | |
| LQDGAGGTEGEGGRK | 26 | P40424 | |
| GGTEGEGGRKQDIGD | 31 | P40424 | |
| PAGGAVKTEGGGSEA | 1081 | P27816 | |
| AGGGDGGILTANEKS | 141 | P35527 | |
| AKAGGSGGAGVTLDE | 56 | Q9ULI0 | |
| DGGSEGSGGNNDGEK | 546 | O15327 | |
| AEEGSSGKKDEGGGG | 761 | Q9UKJ3 | |
| GAQTAEGEGAGGGAK | 626 | Q9UKX2 | |
| ASVDGGSQAVQGGGG | 141 | Q9Y4A8 | |
| LAVSLEEGTGGGGGK | 26 | Q4G148 | |
| EEGTGGGGGKPQAAV | 31 | Q4G148 | |
| AGSGGVNGGEEQGLG | 136 | Q1KMD3 | |
| GLSGEAVGTGEAAGG | 396 | A6NEM1 | |
| GLSGEAVGTGEAAGG | 486 | A6NI86 | |
| GATGAEAEAGGGKKG | 626 | P12882 | |
| QGTGSVDGGAVAAGA | 206 | Q9P0K8 | |
| GGKRSDGEQDGAAGS | 986 | Q7Z6Z7 | |
| GGENTEGGVESGGTA | 621 | Q96M63 | |
| NGVEKGGSGEGGGEE | 421 | Q6NXR0 | |
| KTKDIGGDAGGGTAG | 266 | Q86YJ5 | |
| GSGKDGQLGNGGTRD | 321 | Q9UII4 | |
| AGGSGAGGDSAIEQG | 21 | Q9UBB5 | |
| AGGDSAIEQGGQGSA | 26 | Q9UBB5 | |
| GVGNNSEGGRGKAGA | 1856 | P46100 | |
| QFGEEGLKGGAGGTD | 66 | Q9UDY4 | |
| EGSGGESAGGGDKVS | 176 | Q8WV48 | |
| EFGGGEEGTGLTGIK | 41 | Q9NWK9 | |
| GIGEKGAEGTAGNDG | 781 | P05997 | |
| TGLGFNIVGGEDGEG | 321 | P78352 | |
| LKTDNAGDQHGGGGG | 61 | P14866 | |
| SVGGNKMGEGGFGVV | 186 | Q9NWZ3 | |
| GGIQGGGIQGASKQG | 541 | Q9H0L4 | |
| ESLVAKDGGTGGGTG | 46 | Q04741 | |
| GEKGDAGNSIGGGRG | 371 | Q5TAT6 | |
| QAVGGEGEKISGGGG | 316 | D6RIA3 | |
| GAGGGAQSQGVKEPG | 66 | Q7Z3Z3 | |
| GSEGDGGKGVVRTSE | 1056 | Q7Z2Y5 | |
| LQSAGAGGGGVGDLE | 51 | Q96QE2 | |
| SVVNGDSGKSGGVGD | 171 | Q8NCE0 | |
| GSEAQGAGSGGDAGV | 711 | Q9NRF2 | |
| GASGGGGGTDQDRVK | 126 | P41225 | |
| EKVGPGGSSVGSGDA | 511 | Q8WV44 | |
| GGKDSCQGDSGGPVV | 191 | Q8NHM4 | |
| KNQGGGLSSSGAGEG | 991 | P07814 | |
| ETKTFGGGGGGARSN | 146 | Q9H7E2 | |
| HQGEKGQGGTEGGVG | 531 | Q9BUR4 | |
| IQGGDITTGDGTGGV | 96 | P45877 | |
| GGGGGGQKVSATASI | 101 | Q5TG53 | |
| DEQGGGVGTKDHGGG | 191 | Q9NQV8 | |
| SKSGGGTGEEPGSQG | 171 | O15355 | |
| SFDQKSKDGNGGGGG | 11 | O15266 | |
| IGDGAGVGKGRTVAG | 276 | Q9Y2G9 | |
| GAQTAEAEGGGGKKG | 626 | Q9Y623 | |
| KSAGAQGGEEKDGGG | 61 | P0C7M4 | |
| GSGGGRGAGGEENKE | 26 | Q9UHB9 | |
| GDAAGQKKEDTGGGG | 201 | Q9H2D6 | |
| VGLAVTGGDSEGGRG | 241 | Q9NP94 | |
| ISGYGAAGGKGGKNT | 736 | Q9UM73 | |
| GAGGDVNGTAAVGGL | 76 | P25100 | |
| QGGDQGSGFGTTGKA | 341 | P52594 | |
| GAKGDVGTAGSVGGT | 1026 | Q17RW2 | |
| EGDKNGDGGCGTGGR | 2586 | O15417 | |
| GEKGAEAANVTGPGG | 116 | P67809 | |
| AATGGGSTGEADGKT | 41 | O43242 | |
| NSEGKRGTGAGGDSG | 716 | Q9UMS6 | |
| QAGGEGAGGELGISL | 181 | Q96AQ6 | |
| SIAKARGGNIGDGGG | 581 | P55072 | |
| SRGGGAGEKGSSEGD | 56 | O95935 | |
| TEGGAVGSEIAGGAG | 401 | Q92504 | |
| GGELDGGDAGLGTSQ | 1301 | Q6ZQQ2 | |
| SGGSEEPGGIGVGEK | 1211 | Q9C0C2 | |
| SGEGGDAKSQEGAGT | 1016 | O15015 | |
| GEQGGEAGAAETGGS | 1121 | O95359 | |
| KSAGAQGGEEKDGGG | 61 | Q9BQY4 | |
| GGKDSCQGDSGGPVV | 191 | P07478 | |
| GLEGGTVEGGKVACG | 1911 | Q96JG9 | |
| KVFSGGDTEGNGELG | 311 | Q96C00 | |
| CVSGSGGGGESGRKT | 126 | Q6ZTR6 | |
| GAGGGAAGDKDTKSG | 146 | Q96F45 | |
| VEGVEGKLGNGSGAG | 711 | Q9UPP1 | |
| SGSKDQVGGGGEFGG | 96 | Q9H598 | |
| GGKDSCQGDSGGPVV | 191 | P07477 | |
| GTQGKGTGGQQRGGE | 521 | Q6UX68 | |
| EFEGGGGGEGNVSQV | 21 | Q96S53 | |
| QKDGGKDGAGTQGGE | 376 | Q9BRZ2 | |
| QTDSGGERAGLGGTG | 51 | O75132 | |
| GEGNIQGVGEGGEVG | 531 | Q5BKZ1 | |
| GGGGGDSGKIVINVG | 81 | Q14003 | |
| AGGAGGGVTEEQEGF | 121 | P17275 | |
| GSGDQAGGEGKHITV | 166 | Q9NP98 |